New research shows early Multiple Sclerosis brain damage is dynamic and reversible. Myelin swellings can shrink and disappear ...
This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, ...
New Zealand does not have enough neurologists to keep up with the increase in demand for the diagnosis and treatment of ...
Lower nucleus accumbens volume independently predicts depressive symptoms and future anhedonia in patients with early relapsing-remitting MS.
An international research team has gained new insights into the dynamics of myelin swellings in the brain. Myelin swellings ...
Persistent inflammation may influence neurodegeneration through microglial activation, yet evidence remains hypothesis driven ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton's tyrosine kinase (BTK ...
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in reduc ...
Fenebrutinib numerically reduced the risk of disability progression by 12% compared to OCREVUS as early as 24 weeks; additional analysis showed potential benefit in upper limb function Fenebrutinib ...
News Medical on MSN
Study reveals dynamic nature of myelin swellings
An international research team of Amsterdam UMC, VU LaserLab, the Netherlands Institute for Neuroscience and the University ...
A new AI foundation model from Mass General Brigham may be capable of analyzing brain MRI datasets and predict various ...
At the same time, the need for neurology services is increasing, as new and sometimes more complex treatments became ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results